Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3317122 | Pancreatology | 2014 | 10 Pages |
Abstract
These results provide the first evidence that TTFields serve as an effective antimitotic treatment in preclinical pancreatic cancer models and have a long term negative effect on cancer cell survival. These results make TTFields an attractive candidate for testing in the treatment of patients with pancreatic cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Moshe Giladi, Rosa S. Schneiderman, Yaara Porat, Mijal Munster, Aviran Itzhaki, Daniel Mordechovich, Shay Cahal, Eilon D. Kirson, Uri Weinberg, Yoram Palti,